Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 6/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | RECQL | P46063 | 3/20 | 0.59 |
| ▸ | CASP6 | P55212 | 2/20 | 0.59 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.59 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | PARP1 | P09874 | 3/20 | 0.57 |
| ▸ | APEX1 | P27695 | 2/20 | 0.57 |
| ▸ | RGS12 | O14924 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15709476 | 1.00 | TYMS (0.68) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL6069711 | 0.89 | TYMS (0.54) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL11319242 | 0.87 | TYMS (0.55) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL11333915 | 0.87 | HSD17B10 (0.58) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL29050811 | 0.81 | POLB (0.47) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL30714778 | 0.81 | TYMS (1.00) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL8427336 | 0.81 | TYMS (1.00) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL2811173 | 0.80 | CYP1A2 (0.58) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL13575290 | 0.79 | MEN1 (0.49) | TYMSPOLBTDP1KDM4EL3MBTL1 | |
| SCHEMBL5746130 | 0.77 | MEN1 (0.62) | POLBTDP1KDM4EL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11975032-B2 | Medicament for liver regeneration and for treatment of liver failure | MEDIZINISCHE HOCHSCHULE HANNOVER (DE) | 2024-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11975032-B2 | Medicament for liver regeneration and for treatment of liver failure | PYGL, HNF4A, ATF1 | TYMS 3735/4885POLB 3588/4885TDP1 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.